MET exon 14 skipping defines a unique molecular class of non-small cell lung cancer

PURPOSE: Recurrent MET exon 14 splicing has been revealed in lung cancers and is a promising therapeutic target. Because we have limited knowledge about the natural history of MET mutant tumors, the current study was aiming to determine the clinical and pathological characteristics in non-small cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Difan, Wang, Rui, Ye, Ting, Yu, Su, Hu, Haichuan, Shen, Xuxia, Li, Yuan, Ji, Hongbin, Sun, Yihua, Chen, Haiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173088/
https://www.ncbi.nlm.nih.gov/pubmed/27223439
http://dx.doi.org/10.18632/oncotarget.9541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173088/
https://www.ncbi.nlm.nih.gov/pubmed/27223439
http://dx.doi.org/10.18632/oncotarget.9541

Ejemplares similares